GlaxoSmithKline (GSK)
Create an Alert
51.47
-1.00 -1.91%
NYSE
Jun 19, 5:00PM
BATS Real time
Currency in USD
GlaxoSmithKline Interest Expense:
308.51M for March 31, 2013GlaxoSmithKline Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 308.51M |
| Dec. 31, 2012 | 299.76M |
| Sept. 30, 2012 | 319.79M |
| June 30, 2012 | 296.40M |
| March 31, 2012 | 312.80M |
| Dec. 31, 2011 | 314.48M |
| Sept. 30, 2011 | 297.50M |
| June 30, 2011 | 337.35M |
| March 31, 2011 | 308.99M |
| Dec. 31, 2010 | 372.05M |
| Sept. 30, 2010 | 311.32M |
| June 30, 2010 | 284.51M |
| March 31, 2010 | 309.02M |
| Dec. 31, 2009 | 342.42M |
| Sept. 30, 2009 | 317.83M |
| June 30, 2009 | 278.38M |
| March 31, 2009 | 289.22M |
| Dec. 31, 2008 | 348.68M |
| Sept. 30, 2008 | 392.64M |
| June 30, 2008 | 426.91M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
GSK Interest Expense Benchmarks
| Companies | |
|---|---|
| AstraZeneca | 0.00 |
| Merck | 0.00 |
| Eli Lilly and Company | 40.30M |
GSK Interest Expense Rankings
| Overall |
41st percentile 9838 of 16782 |
| Sector |
28th percentile 1011 of 1410 in Healthcare |
| Industry |
34th percentile 88 of 135 in Drug Manufacturers - Major |
GSK Interest Expense Range, Past 5 Years
| Minimum | 278.38M | Jun 2009 |
| Maximum | 426.91M | Jun 2008 |
| Average | 323.43M |
